Jasper Therapeutics appoints new CEO
Source: SeekingAlpha
2026-01-07 16:35:02 ET
More on Jasper Therapeutics
- Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary ETESIAN Asthma Data - Slideshow
- Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary ETESIAN Asthma Data Transcript
- Seeking Alpha’s Quant Rating on Jasper Therapeutics
- Historical earnings data for Jasper Therapeutics
- Financial information for Jasper Therapeutics
Read the full article on Seeking Alpha
For further details see:
Jasper Therapeutics appoints new CEO
Jasper Therapeutics Inc.
NASDAQ: JSPR
JSPR Trading
4.12% G/L:
$1.39 Last:
286,331 Volume:
$1.32 Open:
JSPR Latest News
February 24, 2026 04:30:00 pm
Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference
January 08, 2026 07:00:00 am
Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria
JSPR Stock Data
$36,659,091
21,939,487
1.06%
33
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
